| Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia -> Monitor Keywords |
|
|
 
Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemiaMethods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia description/claimsThe Patent Description & Claims data below is from USPTO Patent Application 20090117095, Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia. Brief Patent Description - Full Patent Description - Patent Application Claims
This application claims the benefit of U.S. Provisional Application No. 60/509,473, filed Oct. 8, 2003. The U.S. Government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license others on reasonable terms as provided by the terms of Grants No. CA 81554 and CA 87956 awarded by the National Institutes of Health. The present invention generally relates to methods of diagnosis and treatment of B cell chronic lymphocytic leukemia (B-CLL). More particularly, the invention relates to methods of B-CLL diagnosis and treatment based on the presence of sets of B-CLL patients that have B cell receptor genes in common.
Continue reading about Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia... Full patent description for Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia Brief Patent Description - Full Patent Description - Patent Application Claims Click on the above for other options relating to this Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia patent application. Patent Applications in related categories: 20090285795 - method for the production of a monoclonal antibody to cd20 for the treatment of b-cell lymphoma - The present invention relates to the recombinant method used for the production of soluble form of an antibody that binds to CD20 for treatment of patients with relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin's lymphoma (NHL). The treatment will comprise the use of immunologically active anti-CD20 antibodies; or ... 20090285800 - Aberrant expression of cks1 and cks2 and uses thereof - The present invention is drawn to providing a therapeutic strategy for prostate cancer. In this regard, the present invention demonstrates that elevated expression of Cks1 contributes to tumorigenicity of prostate tumor cells by promoting cell growth and elevated expression of Cks2 protects cells from apoptosis. Accordingly, the present invention discloses ... 20090285799 - Antibody antagonists of interleukin-13 receptor alpha1 - Antibody antagonists of human interleukin-13 receptor alpha 1 are disclosed. The antibody molecules are useful in the inhibition of IL-13Rα1-mediated activities and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with hIL-13Rα1 activity. The present invention also discloses nucleic acid encoding said antibody molecules, vectors, ... 20090285801 - Calcium-sensing receptor 2 (car2) and methods for using - The current disclosure provide a novel human calcium sensing receptor named CaR2 and the nucleotide sequence that encodes the receptor. The disclosure further provides antibodies specific for CaR2. Also disclosed are methods of identifying modulators of the receptor and methods of using the identified modulators to treat calcium receptor mediated ... 20090285798 - Cd4 mimic peptides and their uses - An isolated peptide comprising the sequence (I): TPA-Asn-Leu-His-Phe-Cys-Gln-Leu-Xaaa-Cys-Lys-Ser-Leu-Gly-Leu-Leu-Gly-Arg-Cys-Xaab-Xaac-Xaad-Xaae-Cys-Ala-Cys-Val-NH2, wherein: TPA represents thiopropionic acid; Xaaa represents Arg, Lys; Xaab represents Ala, Arg; Xaac represents a D-amino acid; Xaad represents Thr, Ser, Asn; Xaae represents phenylalanine or a phenylalanine derivative having the structure (II), where A is absent or represents S, O, ... 20090285802 - Highly concentrated stabilized igm solution - The present inventors discovered that stable and highly concentrated IgM solutions can be prepared by using, as an additive, a compound comprising a polyvalent cationic ion, such as magnesium chloride or arginine hydrochloride, to suppress IgM aggregation in solutions. ... 20090285796 - Mutant jak3 kinase in human leukemia - In accordance with the invention, a novel activating mutation (alanine 572 to valine) in JAK3 kinase has been discovered in human acute myelogenous leukemia (AML). The mutant JAK3 kinase was confirmed to drive the proliferation and survival of acute megakaryoblastic leukemia (AML-M7). The invention therefore provides, in part, isolated polynucleotides ... 20090285797 - Use of inhibitors of cyp2a6 for regulating nicotine metabolism - The invention relates to methods and compositions for regulating nicotine metabolism. Also provided are methods for screening and assessing substances for regulating nicotine metabolism. Methods are provided for assessing nicotine metabolism. ... ###  How KEYWORD MONITOR works... a FREE service from FreshPatents1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia or other areas of interest. ### Previous Patent Application: Extracellular histones as biomarkers for prognosis and molecular targets for therapy Next Patent Application: Methods and compositions for inhibition of metastasis Industry Class: Drug, bio-affecting and body treating compositions ### FreshPatents.com Support Thank you for viewing the Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia patent info. IP-related news and info Results in 2.4055 seconds Other interesting Feshpatents.com categories: Computers: Graphics , I/O , Processors , Dyn. Storage , Static Storage , Printers paws |
 * Protect your Inventions * US Patent Office filing 
PATENT INFO |
|
